Lantheus Holdings Inc (LNTH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $6.64B
Last updated: Nov 17, 2026 at 11:06 AM ET
Lantheus Holdings Inc (LNTH) P/E Ratio & Valuation History
Lantheus Holdings (LNTH) trades at 17.9x trailing earnings and 4.5x sales. Its P/E of 17.9x is above its 5-year median of 15.2x. Its forward P/E is 14.5x. The median P/E across 10 similar companies is 21.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 23.4% higher over the next year. Its free cash flow yield is 5.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 17.9x |
| Forward P/E | 14.5x |
| Price to sales | 4.5x |
| Price to book | 5.1x |
| EV/EBITDA | 15.1x |
| Price to FCF | 17.7x |
| EV/FCF | 17.4x |
| PEG | 0.6 |
| FCF yield | 5.6% |
Historical Medians
Against its 10-year medians, its P/E is 4.7% above 17.1x, its P/S is 36.4% above 3.3x and its P/B is 16.4% below 6.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 17.9x | 15.2x | 17.1x |
| P/S | 4.5x | 4.3x | 3.3x |
| P/B | 5.1x | 5.9x | 6.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 10.0x in 2023 to 59.0x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $66.55 | 11.4x | 3.0x | 4.0x |
| 2024 | $89.46 | 13.2x | 4.1x | 5.7x |
| 2023 | $62.00 | 10.0x | 3.3x | 5.3x |
| 2022 | $50.96 | 12.1x | 3.8x | 7.8x |
| 2021 | $28.89 | 59.0x | 4.6x | 4.2x |
| 2020 | $13.49 | 23.7x | 2.1x | 1.8x |
| 2019 | $20.51 | 17.5x | 2.4x | 7.2x |
| 2018 | $15.65 | 16.3x | 1.8x | 8.7x |
| 2017 | $20.45 | 19.3x | 2.4x | 34.5x |
| 2016 | $8.60 | 11.9x | 0.9x | N/A |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About LNTH
What is LNTH's forward P/E ratio?
Lantheus Holdings has a forward P/E ratio of 14.5x.
Is LNTH stock overvalued?
GNG's valuation label for LNTH is Fairly valued. Its P/E of 17.9x compares with a median of 21.8x across 10 similar companies.
What is LNTH's price to sales ratio?
Lantheus Holdings has a price to sales ratio of 4.5x.
What is Lantheus Holdings's average P/E ratio over 5 years?
Lantheus Holdings's median P/E over the last 5 years is 15.2x, from 60 month-end values through Oct 2026.
What is LNTH's PEG ratio?
Lantheus Holdings has a PEG ratio of 0.6.
LNTH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts